Corporate Support

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

-6.1 (-0.20%)


  • STI Straits Times Index
    -6.1 (-0.20%)
  • KLCI FTSE Bursa Malaysia KLCI
    4.8 (0.32%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    130.0 (0.55%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    -3.0 (-0.09%)
    Index delayed 15 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market


NYSE American Market

  • Volume: 999.1M
  • Value: 1,285.9M
  • Rise: 105
  • Fall: 235
  • Unch: 421

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
QT Vascular0.007+0.001
CapLand IntCom T2.070-0.030
Genting Sing0.745-0.015
Mapletree Log Tr1.870-
Hatten Land0.054+0.001
Medtecs Intl0.410+0.005
Sembcorp Marine0.083-0.001

World Indices

World Indices
Name Last Change
Nasdaq 15,537.7 -245.1
HSI 23,788.9 +130.0
HSCEI 8,506.4 +80.1
Jakarta 6,583.8 +76.1
Nikkei 225 27,935.6
SSE Comp 3,573.8 -3.0
Shanghai A 3,745.8 -3.1
Shanghai B 283.1 +1.3
KOSPI 2,945.3 +45.5

Nikkei 225 updated at end-of-day. Other Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

  • Factsheet

  • Print

Quotes 10 Minutes Delayed. Updated at 02 Dec 2021 17:11
Last (SGD): 0.007 Change: +0.001 High: 0.008 Remarks: -
Change (%): +16.67 Low: 0.006

Company Background

The Group is engaged in the design, assembly and distribution of advanced therapeutic solutions for the minimally invasive treatment of complex vascular diseases. The Group collaborates with industry specialists and physicians who are key opinion leaders to develop and offer physicians and patients new and differentiated devices to improve outcomes in complex peripheral and coronary interventions.

Click to show Stock Prices chart

Key Statistics

EPS (SGD) a -0.00442 Trailing EPS (SGD) b -0.00212 NAV (SGD) c -0.0003
PE a - Trailing PE d - Price / NAV c -23.3333
Dividend Yield (%) e - Cash In Hand (SGD) f 0.0001 Issued & Paid-up Shares g 2,268,306,000
Piotroski F Score 2 Market Cap (M) 15.878 Free Float (%) 85.3
Return on Equity (ROE) (%) h n.m. Revenue Growth (%) TTM i -92.097
Net Earnings Growth (%) j 59.301 Net Debt/Equity k n.a.
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Manufacturing - Drugstore Chains
Category Classification Medical & Biotechnology
Index Components FTSE ST Catalist Index
  1. Based on latest Full Year results announcement, adjusted based on Profit Attributable To Shareholders.
  2. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  3. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  4. Based on latest Full Year results announcement, adjusted for the current number of shares.
  5. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  6. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  7. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 02 Dec 2021. Please click here for more information.
  8. Calculated based on Net Earnings / (Shareholders' Equity - Other Share Capital)
  9. Calculated based on (Current Year Revenue - Last Year Revenue) / Last Year Revenue
  10. Calculated based on (Current Year Earnings - Last Year Earnings) / Last Year Earnings
  11. Calculated based on (Long Term Debt + Short Term Debt - Cash and Short Term Investments)/(Shareholders' Equity - Other Share Capital)

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.001
-12.50 %
10 Days --0.003
-30.00 %
20 Days --0.001
-12.50 %
Medium Term Return 3 Months -+0.003
+75.00 %
6 Months ---
1 Year ---
Long Term Return 2 Years -+0.004
+133.33 %
3 Years --0.002
-22.22 %
5 Years --0.087
-92.55 %
Annualised Return Annualised --
-40.52 %
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference QT Vascular SGX 15.878 - - -23.3333 -
Industry Drugstore Chains SGX 15.878 0.222 - 11.2310 -
Medical & Biotechnology SGX 1,028.042 18.973 16.126 1.4743 1.910
Index FTSE ST Catalist Index SGX 60.928 26.502 20.774 1.3900 1.987
Global Peer CVS HEALTH CORPORATION NYSE 117,194.927 16.325 15.467 1.5772 2.236
Global Peer WALGREENS BOOTS ALLIANCE INC NASDAQ 37,844.557 17.047 17.047 1.6160 4.322
Global Peer PING AN HEALTHCARE & TECHNO CO LTD HKEx 31,263.653 - - 1.7332 -
Global Peer RITE AID CORP NYSE 642.485 - - 1.2715 -
Global Peer PETMED EXPRESS INC NASDAQ 569.019 18.594 22.580 4.0220 4.203
Global Peer BEST & LESS GROUP HOLDINGS LTD ASX 435.023 5.356 5.356 10.0872 -
Global Peer 111 INC ADS EACH REP 2 ORD SHS CL A NASDAQ 171.088 - - -13.6398 -
Global Peer CHINA JO-JO DRUGSTORES INC NASDAQ 20.254 - - 0.7867 -
Global Peer MEDILAND PHARM LTD ASX 22.519 - - 7.4227 -
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

More Information Available

More information is available to our subscribers, including:

  • Consensus Estimates
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.


While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.